Infect Chemother.
2022 Jun;54(2):391-391. 10.3947/ic.2022.0300.
Erratum: Fluvoxamine Treatment of Patients with Symptomatic COVID-19 in a Community Treatment Center: A Preliminary Result of Randomized Controlled Trial
- KMID: 2531035
- DOI: http://doi.org/10.3947/ic.2022.0300
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Fluvoxamine Treatment of Patients with Symptomatic COVID-19 in a Community Treatment Center: A Preliminary Result of Randomized Controlled Trial
- Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
- Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
- Convalescent plasma in COVID-19: renewed focus on the timing and effectiveness of an old therapy
- An Open Label Randomized Controlled Trial of Ivermectin Plus Favipiravir-Based Standard of Care versus Favipiravir-Based Standard of Care for Treatment of Moderate COVID-19 in Thailand
